Sagimet Biosciences announces positive topline results from phase 2b trial of denifanstat
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
The workshop was conducted as a part of the NITI–State workshop series
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
The companies will work with investigators to share the results with the scientific community
Alleviating staff shortages by empowering surgeons with greater personalization and control
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Subscribe To Our Newsletter & Stay Updated